Cresco Labs (CRLBF) Other Non Operating Income (2019 - 2026)
Cresco Labs (CRLBF) posted Other Non Operating Income of $960000.0 for Q1 2026, down 63.96% on a QoQ basis from $2.7 million in Q4 2025, and up 176.66% year-over-year from $347000.0 in Q1 2025.
Cresco Labs (CRLBF) Other Non Operating Income (2019 - 2026) Analysis & Trends
Cresco Labs' Other Non Operating Income history runs 8 years deep, the most recent figure standing at $960000.0 for Q1 2026.
- Quarterly Other Non Operating Income rose 176.66% year-over-year to $960000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.6 million (up 83.06% YoY) and the FY2025 annual result came in at -$11.2 million, up 82.38% from the prior year.
- Other Non Operating Income was $960000.0 for Q1 2026 at Cresco Labs, down from $2.7 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $14.8 million in Q3 2022 and bottomed at -$59.5 million in Q2 2024.
- A 5-year average of -$3.2 million and a median of $347000.0 in 2025 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income surged 752.85% — and 2025, when it slumped 267140.0%.
- Cresco Labs' Other Non Operating Income stood at $2.5 million in 2022, then slumped by 98.02% to $50000.0 in 2023, then plunged by 6644.0% to -$3.3 million in 2024, then surged by 181.42% to $2.7 million in 2025, then slumped by 63.96% to $960000.0 in 2026.
- Business Quant data shows CRLBF's Other Non Operating Income at $960000.0 in Q1 2026, $2.7 million in Q4 2025, and -$13.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 960,000.00 |
| Dec 31, 2025 | 2.66 Mn |
| Sep 30, 2025 | -13.36 Mn |
| Jun 30, 2025 | -836,000.00 |
| Mar 31, 2025 | 347,000.00 |
| Dec 31, 2024 | -3.27 Mn |
| Sep 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -59.51 Mn |
| Mar 31, 2024 | 856,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | 329,000.00 |
| Jun 30, 2023 | 402,000.00 |
| Mar 31, 2023 | 959,000.00 |
| Dec 31, 2022 | 2.52 Mn |
| Sep 30, 2022 | 14.80 Mn |
| Jun 30, 2022 | 4.68 Mn |
| Mar 31, 2022 | -6.77 Mn |
| Dec 31, 2021 | 10.91 Mn |
| Sep 30, 2021 | 1.74 Mn |
| Jun 30, 2021 | 12.73 Mn |